Friday, 6 March 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 06 March 2026
News

Global CEO quits for life in Australia

Posted 6 March 2026 PM

Bavarian Nordic CEO, Paul Chaplin, is resigning from his position to set up a life in Australia with his family.

Chaplin has been with the Danish vaccine maker since 1999 and was appointed CEO in 2014. Under his leadership, Bavarian Nordic has grown from a small research-based company with a single government customer to a large vaccine manufacture, known for its smallpox and mpox jabs.

To see the whole article, please login

Popular

Fresh PBAC agenda drops
Pharma faces biggest ever payout
Pharma's gender pay gap worsens
Aussie MSD dodges reorganisation
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home